Literature DB >> 15451144

Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases.

Jean-Luc Cracowski1, Olivier Ormezzano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15451144     DOI： 10.1016/j.ehj.2004.07.031

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

Review 1.  Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis.

Authors:  Jayson V Pagaduan; Vishal Sahore; Adam T Woolley
Journal:  Anal Bioanal Chem       Date:  2015-04-09       Impact factor: 4.142

2.  Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.

Authors:  MaryFran Sowers; Daniel McConnell; Mary L Jannausch; John F Randolph; Robert Brook; Ellen B Gold; Sybil Crawford; Bill Lasley
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

3.  Microextraction by Packed Sorbent (MEPS) and Solid-Phase Microextraction (SPME) as Sample Preparation Procedures for the Metabolomic Profiling of Urine.

Authors:  Catarina Silva; Carina Cavaco; Rosa Perestrelo; Jorge Pereira; José S Câmara
Journal:  Metabolites       Date:  2014-01-27

Review 4.  Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis.

Authors:  Shyamala Thirunavukkarasu; Shabaana A Khader
Journal:  Front Cell Infect Microbiol       Date:  2019-04-18       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.